Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells after Influenza Virus Infection

Journal of Interferon and Cytokine Research

Volumn 35, Issue 7, 2015, Pages 554-562

  Fox, Julie M ^a   Crabtree, Jackelyn M ^a   Sage, Leo K ^a   Tompkins, S Mark ^a   Tripp, Ralph A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON; INTERFERON LAMBDA; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; CYTOKINE; IDO1 PROTEIN, MOUSE; IL29 PROTEIN, HUMAN; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; INTERFERON-LAMBDA PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLUENZA A (H1N1); MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL SURVIVAL; DOG; ENZYMOLOGY; EPITHELIUM CELL; INFLUENZA; LUNG; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; VIROLOGY; VIRUS LOAD;

ORTHOMYXOVIRIDAE;

ANIMALS; CELL DEATH; CELL LINE; CELL SURVIVAL; CYTOKINES; DOGS; EPITHELIAL CELLS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLUENZA, HUMAN; INTERLEUKINS; LUNG; MICE; ORTHOMYXOVIRIDAE INFECTIONS; UP-REGULATION; VIRAL LOAD;

EID: 84936993998     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0052     Document Type: Article

References (35)

1. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180(4):2474-2485.
2. Ank N, Paludan SR. 2009. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 35(1): 82-87.
3. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJ, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermiin LS, Hunt NH. 2007. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396(1):203-213.
4. Ball HJ, Yuasa HJ, Austin CJD, Weiser S, Hunt NH. 2009. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol 41(3):467-471.
5. Bell LV, Else KJ. 2011. Regulation of colonic epithelial cell turnover by IDO contributes to the innate susceptibility of SCID mice to Trichuris muris infection. Parasite Immunol 33(4):244-249.
6. Bianchi M, Bertini R, Ghezzi P. 1988. Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines. Biochem Biophys Res Commun 152(1):237-242.
7. Chan RW, Yuen KM, Yu WC, Ho CC, Nicholls JM, Peiris JS, Chan MC. 2010. Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS One 5(1):e8713.
8. Chi B, Dickensheets HL, Spann KM, Alston MA, Luongo C, Dumoutier L, Huang J, Renauld JC, Kotenko SV, Roederer M, Beeler JA, Donnelly RP, Collins PL, Rabin RL. 2006. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol 80(10):5032-5040.
9. Commins S, Steinke JW, Borish L. 2008. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121(5):1108-1111.
10. de Weerd NA, Samarajiwa SA, Hertzog PJ. 2007. Type I interferon receptors: biochemistry and biological functions. J Biol Chem 282(28):20053-20057.
11. Fallarino F, Vacca C, Orabona C, Belladonna ML, Bianchi R, Marshall B, Keskin DB, Mellor AL, Fioretti MC, Grohmann U, Puccetti P. 2002. Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha( + ) dendritic cells. Int Immunol 14(1):65-68.
12. Fox JM, Sage LK, Huang L, Barber J, Klonowski KD, Mellor AL, Tompkins SM, Tripp RA. 2013. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection. J Gen Virol 94(Pt 7):1451-1461.
13. Hirata F, Hayaishi O. 1975. Studies on indoleamine 2,3- dioxygenase. I. Superoxide anion as substrate. J Biol Chem 250(15):5960-5966.
14. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL. 2006. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 80(15):7469-7480.
15. Jacoby DB, Choi AM. 1994. Influenza virus induces expression of antioxidant genes in human epithelial cells. Free Radic Biol Med 16(6):821-824.
16. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE. 2010. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84(21):11515-11522.
17. Lob S, Konigsrainer A, Zieker D, Brucher BL, Rammensee HG, Opelz G, Terness P. 2009. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother 58(1):153-157.
18. Maiwald S, Wehner R, Schmitz M, Bornhauser M, Loeb S, Wassmuth R. 2011. IDO1 and IDO2 gene expression analysis by quantitative polymerase chain reaction. Tissue Antigens 77(2):136-142.
19. Maneglier B, Rogez-Kreuz C, Spreux-Varoquaux O, Malleret B, Therond P, Samah B, Drouet I, Dormont D, Advenier C, Clayette P. 2007. Comparative effects of two type I interferons, human IFN-alpha and ovine IFN-tau on indoleamine- 2,3-dioxygenase in primary cultures of human macrophages. Fundam Clin Pharmacol 21(1):29-34.
20. Matrosovich M, Matrosovich T, Garten W, Klenk HD. 2006. New low-viscosity overlay medium for viral plaque assays. Virol J 3:63.
21. Meininger D, Zalameda L, Liu Y, Stepan LP, Borges L, McCarter JD, Sutherland CL. 2011. Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. Biochim Biophys Acta 1814(12):1947-1954.
22. Mennechet FJ, Uze G. 2006. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3- expressing suppressor T cells. Blood 107(11):4417-4423.
23. Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. 2007. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res 67(15):7082-7087.
24. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL. 2005. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22(5):633-642.
25. Oshansky CM, Barber JP, Crabtree J, Tripp RA. 2010. Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. J Infect Dis 201(8):1201-1207.
26. Oshansky CM, Pickens JA, Bradley KC, Jones LP, Saavedra- Ebner GM, Barber JP, Crabtree JM, Steinhauer DA, Tompkins SM, Tripp RA. 2011. Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid alpha 2, 3 residues. PLoS One 6(6):e21183.
27. Popov A, Abdullah Z, Wickenhauser C, Saric T, Driesen J, Hanisch FG, Domann E, Raven EL, Dehus O, Hermann C, Eggle D, Debey S, Chakraborty T, Kronke M, Utermohlen O, Schultze JL. 2006. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 116(12):3160-3170.
28. Qian F, Liao J, Villella J, Edwards R, Kalinski P, Lele S, Shrikant P, Odunsi K. 2012. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation. Cancer Immunol Immunother.
29. Reed LJ, Meunch H. 1938. A simple method for estimating fifty percent endpoints. Am J Hygiene 27:493-497.
30. Sanders CJ, Doherty PC, Thomas PG. 2010. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res 343(1):13-21.
31. Smith JH, Brooks P, Johnson S, Tompkins SM, Custer KM, Haas DL, Mair R, Papania M, Tripp RA. 2011. Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice. Vaccine 29(14):2568-2575.
32. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFNlambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4(3):e1000017.
33. van Wissen M, Snoek M, Smids B, Jansen HM, Lutter R. 2002. IFN-gamma amplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. J Immunol 169(12):7039-7044.
34. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol 182(3):1296-1304.
35. Zeng H, Goldsmith CS, Maines TR, Belser JA, Gustin KM, Pekosz A, Zaki SR, Katz JM, Tumpey TM. 2013. Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures. J Virol 87(5):2597-2607.